"Acetates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
Descriptor ID |
D000085
|
MeSH Number(s) |
D02.241.081.018 D10.251.400.045
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acetates".
Below are MeSH descriptors whose meaning is more specific than "Acetates".
This graph shows the total number of publications written about "Acetates" by people in this website by year, and whether "Acetates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 2 | 0 | 2 |
1997 | 0 | 1 | 1 |
1998 | 2 | 1 | 3 |
1999 | 1 | 1 | 2 |
2000 | 5 | 1 | 6 |
2001 | 0 | 1 | 1 |
2002 | 1 | 1 | 2 |
2003 | 2 | 0 | 2 |
2004 | 1 | 1 | 2 |
2008 | 0 | 3 | 3 |
2009 | 1 | 1 | 2 |
2010 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 4 | 1 | 5 |
2015 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
2017 | 2 | 2 | 4 |
2018 | 3 | 0 | 3 |
2019 | 1 | 1 | 2 |
2020 | 0 | 5 | 5 |
2021 | 0 | 3 | 3 |
2022 | 0 | 2 | 2 |
2023 | 1 | 1 | 2 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetates" by people in Profiles.
-
Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients. J Pediatric Infect Dis Soc. 2024 Feb 28; 13(Supplement_1):S14-S21.
-
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):783-794.
-
Lessons Learned From the First-In-Human Compassionate Use of Connect-EA? in Ten Patients With Esophageal Atresia. J Pediatr Surg. 2024 Mar; 59(3):437-444.
-
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 08 01; 78(2):397-415.
-
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology. 2022 Oct; 54(6):686-693.
-
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis. J Hepatol. 2022 08; 77(2):353-364.
-
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis. 2021 10 20; 73(8):1346-1354.
-
Use of Uridine Triacetate to Reverse Severe Persistent Myelosuppression Following 5-fluorouracil Exposure in a Patient With a c.557A>G Heterozygous DPYD Variant. Clin Colorectal Cancer. 2021 09; 20(3):273-278.
-
Ethyl acetate extract of Clausena excavata induces growth inhibition of non-small-lung cancer, NCI-H460, cell line via apoptosis. J Appl Biomed. 2021 03; 19(1):40-47.
-
Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective. J Med Virol. 2021 06; 93(6):3786-3794.